» Articles » PMID: 28634873

Evaluating Two Evidence-Based Intervention Strategies to Promote CRC Screening Among Latino Adults in a Primary Care Setting

Abstract

Regular use of colorectal cancer screening can reduce incidence and mortality, but participation rates remain low among low-income, Spanish-speaking Latino adults. We conducted two distinct pilot studies testing the implementation of evidence-based interventions to promote fecal immunochemical test (FIT) screening among Latinos aged 50-75 years who were not up-to-date with CRC screening (n = 200) at a large Federally Qualified Health Center (FQHC) in San Diego, CA. One pilot focused on an opportunistic clinic visit "in-reach" intervention including a 30-min session with a patient navigator, review of an educational "flip-chart," and a take-home FIT kit with instructions. The second pilot was a system-level "outreach" intervention consisting of mailed materials (i.e., FIT kit, culturally and linguistically tailored instructions, and a pre-paid return envelope). Both received follow-up calls to promote screening completion and referrals for additional screening and treatment if needed. The primary outcome was FIT kit completion and return within 3 months assessed through electronic medical records. The in-reach pilot consisted of mostly insured (85%), women (82%), and Spanish-speaking (88%) patients. The outreach pilot consisted of mostly of Spanish-speaking (73%) women (64%), half of which were insured (50%). At a 3-month follow-up, screening completion was 76% for in-reach and 19% for outreach. These data demonstrate that evidence-based strategies to promote CRC screening can be implemented successfully within FQHCs, but implementation (particularly of mailed outreach) may require setting and population-specific optimization. Patient, provider, and healthcare system related implementation approaches and lessons learned from this study may be implemented in other primary care settings.

Citing Articles

A socioecological taxonomy of determinants to colorectal cancer screening in black men: Insights from a mixed-methods systematic review.

Zaire P, Miller E, Ewing A, Hefner J, Wright K, Smith L Prev Med Rep. 2025; 49:102954.

PMID: 39834382 PMC: 11743892. DOI: 10.1016/j.pmedr.2024.102954.


Improving Guideline-Recommended Colorectal Cancer Screening in a Federally Qualified Health Center (FQHC): Implementing a Patient Navigation and Practice Facilitation Intervention to Promote Health Equity.

Glaser K, Crabtree-Ide C, McNulty A, Attwood K, Flores T, Krolikowski A Int J Environ Res Public Health. 2024; 21(2).

PMID: 38397617 PMC: 10887785. DOI: 10.3390/ijerph21020126.


Clinic Factors Associated With Mailed Fecal Immunochemical Test (FIT) Completion: The Difference-Making Role of Support Staff.

Davis M, Schneider J, Petrik A, Miech E, Younger B, Escaron A Ann Fam Med. 2022; 20(2):123-129.

PMID: 35346927 PMC: 8959740. DOI: 10.1370/afm.2772.


Source matters: a survey of cost variation for fecal immunochemical tests in primary care.

Coury J, Ramsey K, Gunn R, Judkins J, Davis M BMC Health Serv Res. 2022; 22(1):204.

PMID: 35168616 PMC: 8845335. DOI: 10.1186/s12913-022-07576-4.


An observational study of workflows to support fecal testing for colorectal cancer screening in primary care practices serving Medicaid enrollees.

Mojica C, Gunn R, Pham R, Miech E, Romer A, Renfro S BMC Cancer. 2022; 22(1):106.

PMID: 35078444 PMC: 8787027. DOI: 10.1186/s12885-021-09106-7.


References
1.
Wells K, Roetzheim R . Health disparities in receipt of screening mammography in Latinas: a critical review of recent literature. Cancer Control. 2007; 14(4):369-79. DOI: 10.1177/107327480701400407. View

2.
Goebel M, Singal A, Nodora J, Castaneda S, Martinez E, Doubeni C . How can we boost colorectal and hepatocellular cancer screening among underserved populations?. Curr Gastroenterol Rep. 2015; 17(6):22. PMC: 8248527. DOI: 10.1007/s11894-015-0445-1. View

3.
Frazier E, Jiles R, Mayberry R . Use of screening mammography and clinical breast examinations among black, Hispanic, and white women. Prev Med. 1996; 25(2):118-25. DOI: 10.1006/pmed.1996.0037. View

4.
Ramirez A, Perez-Stable E, Talavera G, Penedo F, Carrillo J, Fernandez M . Time to definitive diagnosis of breast cancer in Latina and non-Hispanic white women: the six cities study. Springerplus. 2013; 2(1):84. PMC: 3601250. DOI: 10.1186/2193-1801-2-84. View

5.
Gonzalez P, Castaneda S, Mills P, Talavera G, Elder J, Gallo L . Determinants of breast, cervical and colorectal cancer screening adherence in Mexican-American women. J Community Health. 2011; 37(2):421-33. PMC: 3296890. DOI: 10.1007/s10900-011-9459-2. View